STAAR Surgical ROE 2010-2024 | STAA

Current and historical return on equity (ROE) values for STAAR Surgical (STAA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STAAR Surgical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.02B $0.43B 5.45%
2024-06-30 $0.02B $0.41B 4.34%
2024-03-31 $0.02B $0.39B 4.23%
2023-12-31 $0.02B $0.39B 6.04%
2023-09-30 $0.02B $0.38B 5.97%
2023-06-30 $0.03B $0.35B 7.71%
2023-03-31 $0.03B $0.34B 10.20%
2022-12-31 $0.04B $0.34B 13.00%
2022-09-30 $0.04B $0.32B 14.21%
2022-06-30 $0.04B $0.30B 13.67%
2022-03-31 $0.03B $0.28B 12.95%
2021-12-31 $0.03B $0.26B 11.70%
2021-09-30 $0.02B $0.25B 10.28%
2021-06-30 $0.02B $0.24B 10.10%
2021-03-31 $0.01B $0.21B 5.70%
2020-12-31 $0.01B $0.20B 3.32%
2020-09-30 $0.01B $0.19B 5.25%
2020-06-30 $0.01B $0.18B 4.31%
2020-03-31 $0.01B $0.17B 7.77%
2019-12-31 $0.01B $0.16B 8.81%
2019-09-30 $0.01B $0.15B 5.69%
2019-06-30 $0.01B $0.14B 5.17%
2019-03-31 $0.01B $0.14B 4.45%
2018-12-31 $0.01B $0.13B 5.59%
2018-09-30 $0.00B $0.13B 5.95%
2018-06-30 $0.00B $0.05B 8.84%
2018-03-31 $0.00B $0.05B 2.38%
2017-12-31 $-0.00B $0.04B -5.03%
2017-09-30 $-0.00B $0.04B -5.19%
2017-06-30 $-0.01B $0.04B -13.25%
2017-03-31 $-0.01B $0.04B -15.89%
2016-12-31 $-0.01B $0.04B -31.58%
2016-09-30 $-0.01B $0.04B -33.99%
2016-06-30 $-0.01B $0.04B -33.55%
2016-03-31 $-0.01B $0.04B -33.12%
2015-12-31 $-0.01B $0.04B -18.06%
2015-09-30 $-0.01B $0.04B -23.53%
2015-06-30 $-0.01B $0.04B -25.97%
2015-03-31 $-0.01B $0.04B -25.64%
2014-12-31 $-0.01B $0.04B -22.36%
2014-09-30 $-0.01B $0.04B -17.18%
2014-06-30 $-0.00B $0.04B -7.50%
2014-03-31 $-0.00B $0.04B -2.61%
2013-12-31 $0.00B $0.04B 0.00%
2013-09-30 $0.00B $0.04B 0.00%
2013-06-30 $-0.00B $0.04B -3.01%
2013-03-31 $-0.00B $0.03B -3.10%
2012-12-31 $-0.00B $0.03B -3.15%
2012-09-30 $0.00B $0.03B 0.00%
2012-06-30 $0.00B $0.03B 0.00%
2012-03-31 $0.00B $0.03B 3.51%
2011-12-31 $0.00B $0.03B 3.77%
2011-09-30 $0.00B $0.03B 0.00%
2011-06-30 $-0.00B $0.03B -4.30%
2011-03-31 $-0.00B $0.02B -17.98%
2010-12-31 $0.00B $0.02B 0.00%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $-0.00B $0.02B -4.55%
2010-03-31 $0.00B $0.02B 0.00%
2009-12-31 $-0.01B $0.02B -30.00%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.521B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95